TapewireFind a company

person · Reporting owner

Williams R Sanders

Disclosed activity across 4 companies

Tapewire entity
11492
SEC CIK
0001375347

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AMGEN INCAMGN · Entity 2832DirectorMay 19, 2023May 23, 2023
BRISTOL MYERS SQUIBB COBMY · Entity 1662DirectorFebruary 01, 2013February 05, 2013
LABCORP HOLDINGS INC.LH · Entity 1277DirectorFebruary 06, 2024February 08, 2024
Tenaya Therapeutics, Inc.TNYA · Entity 6506DirectorMay 28, 2026May 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMGEN INC

Report date May 19, 2023 · Filed May 23, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,240 Reported balance After 2023-05-19 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-05-19 · Grant · Acquired 939 · Balance 6,240

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

BRISTOL MYERS SQUIBB CO

Report date February 01, 2013 · Filed February 05, 2013

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Share UnitsSEC Table II · derivative / convertible securityDirect48,335.71 Reported balance After 2013-02-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2013-02-01 · Grant · Acquired 4,364 · Balance 48,335.71

F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Filing footnotes · ownership attribution and instrument terms

F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

LABCORP HOLDINGS INC.

Report date February 06, 2024 · Filed February 08, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect8,120 Reported balance After 2024-02-07 transaction · row 1
1 source row

Row 1 · 2024-02-07 · Exercise / conversion · Acquired 947 · Balance 8,120

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect1,183 Reported balance After 2024-02-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2024-02-06 · Grant · Acquired 236 · Balance 1,183

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: The Restricted Stock Units vest fully on February 6, 2025.

F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect236 Reported balance After 2024-02-07 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2024-02-07 · Exercise / conversion · Disposed 947 · Balance 236

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F4: The Restricted Stock Units vested fully on February 7, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: The Restricted Stock Units vest fully on February 6, 2025.

F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc.

F4: The Restricted Stock Units vested fully on February 7, 2024.

Tenaya Therapeutics, Inc.

Report date May 28, 2026 · Filed May 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2036-05-27Direct120,000 Reported balance After 2026-05-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-05-28 · Grant · Acquired 120,000 · Balance 120,000

F1: Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 12, 2019 Filed Feb 14, 2019 21:18 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 1,038 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-005996 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Read SEC document
November 27, 2018 Filed Nov 29, 2018 15:00 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 350 $162.14 $56,749.00
Disclosure

SEC source: 0001127602-18-034638 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,886

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
April 27, 2018 Filed May 1, 2018 22:57 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,127 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-015831 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,136

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 14:15 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 1,038 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-005651 · form4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,038

Underlying: Common Stock · 1,038 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2019.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 07, 2018 Filed Feb 9, 2018 20:57 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 1,263 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-004897 · form4.xml · derivative · entry 2

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,263 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018.

Read SEC document
February 07, 2018 Filed Feb 9, 2018 20:57 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 1,263 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-18-004897 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionNon-qualified Stock Options · Derivative 3,100 $0.00 Strike: $77.19 $0.00
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · derivative · entry 6

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,100 shares

Expires 2020-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 11 $156.92 $1,726.12
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 5

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,973

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 8 $156.91 $1,255.28
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 4

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,984

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 2,881 $156.90 $452,020.55
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 3

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,992

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 200 $156.68 $31,336.26
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 2

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,873

Read SEC document
August 11, 2017 Filed Aug 15, 2017 19:03 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 3,100 $77.19 $239,289.00
Disclosure

SEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2017 Filed May 4, 2017 00:42 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,230 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-016745 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,009

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Read SEC document
February 09, 2017 Filed Feb 13, 2017 18:58 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 1,560 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-005293 · form4.xml · derivative · entry 2

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,263

Underlying: Common Stock · 1,560 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 9, 2017.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 9, 2017.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 09, 2017 Filed Feb 13, 2017 18:58 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 1,560 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-005293 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

Read SEC document
February 07, 2017 Filed Feb 9, 2017 19:15 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 1,263 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-004716 · form4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,823

Underlying: Common Stock · 1,263 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 7, 2018.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
May 03, 2016 Filed May 6, 2016 00:13 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,279 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-051284 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,779

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Read SEC document
April 24, 2015 Filed Apr 28, 2015 23:32 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 1,191 $0.00 $0.00
Disclosure

SEC source: 0001127602-15-015465 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Read SEC document
October 30, 2014 Filed Oct 31, 2014 20:16 UTC AMGEN INC AMGN · Entity 2832 GrantCommon Stock 309 $0.00 $0.00
Disclosure

SEC source: 0001127602-14-030662 · form4.xml · nonDerivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Read SEC document
February 01, 2013 Filed Feb 5, 2013 21:19 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 4,364 $36.66 $159,984.24
Disclosure

SEC source: 0001225208-13-002986 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,335.71

Underlying: Common Stock, $0.10 par value · 4,364 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2012 Filed Feb 3, 2012 21:33 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 4,313 $32.46 $139,999.98
Disclosure

SEC source: 0001225208-12-003080 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,285.91

Underlying: Common Stock, $0.10 par value · 4,313 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2011 Filed Feb 3, 2011 20:43 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 4,935 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-004713 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,342.73

Underlying: Common Stock, $0.10 par value · 4,935 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2010 Filed Jan 4, 2011 19:41 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 506.69 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-000487 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,003.82

Underlying: Common Stock, $0.10 par value · 506.69 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2010 Filed Oct 4, 2010 20:10 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 492.58 $0.00 $0.00
Disclosure

SEC source: 0001225208-10-021990 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,141.47

Underlying: Common Stock, $0.10 par value · 492.58 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2010 Filed Jul 2, 2010 20:38 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 537.93 $0.00 $0.00
Disclosure

SEC source: 0001225208-10-016522 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,280.73

Underlying: Common Stock, $0.10 par value · 537.93 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2010 Filed Apr 2, 2010 18:23 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 506.12 $0.00 $0.00
Disclosure

SEC source: 0001225208-10-009609 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,383.09

Underlying: Common Stock, $0.10 par value · 506.12 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2010 Filed Feb 2, 2010 18:31 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 4,490 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-10-003018 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,575.45

Underlying: Common Stock, $0.10 par value · 4,490 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2009 Filed Jan 5, 2010 21:11 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 569.07 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-10-000626 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,085.45

Underlying: Common Stock, $0.10 par value · 569.07 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2009 Filed Oct 2, 2009 17:29 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 553.59 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-019891 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,201.67

Underlying: Common Stock, $0.10 par value · 553.59 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2009 Filed Jul 2, 2009 20:16 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 611.55 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-015041 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,345.93

Underlying: Common Stock, $0.10 par value · 611.55 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2009 Filed Apr 2, 2009 15:04 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 578.71 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-009470 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,405.94

Underlying: Common Stock, $0.10 par value · 578.71 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 02, 2009 Filed Feb 26, 2009 16:55 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 5,093 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-004963 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,827.23

Underlying: Common Stock, $0.10 par value · 5,093 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2008 Filed Jan 5, 2009 22:07 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 542.77 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-000505 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,530.05

Underlying: Common Stock, $0.10 par value · 542.77 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2008 Filed Oct 2, 2008 19:06 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 661.12 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-08-015559 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,781.39

Underlying: Common Stock, $0.10 par value · 661.12 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2008 Filed Jul 2, 2008 20:45 UTC BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 756.09 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-08-011380 · doc4.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,159.14

Underlying: Common Stock, $0.10 par value · 756.09 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 30, 2008 Filed Jul 17, 2008 21:31 UTC Amendment BRISTOL MYERS SQUIBB CO BMY · Entity 1662 GrantDeferred Share Units · Derivative 1,528.31 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-08-012139 · doc4a.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,931.36

Underlying: Common Stock, $0.10 par value · 1,528.31 shares

Expires not disclosed

F1 · security: This Form 4 is being amended to correct the number of deferred share units that were acquired on June 30, 2008.

F2 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F3 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2008 Filed Apr 2, 2008 20:42 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 632.02 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-08-000131 · wil855.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,248.68

Underlying: Common Stock, $0.10 par value · 632.02 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2008 Filed Feb 5, 2008 21:27 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 4,648 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-08-000048 · wil793.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,616.66

Underlying: Common Stock, $0.10 par value · 4,648 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2007 Filed Jan 3, 2008 22:08 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 441.78 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-08-000013 · wil774.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,794.66

Underlying: Common Stock, $0.10 par value · 441.78 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

Read SEC document
September 28, 2007 Filed Oct 2, 2007 21:05 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 375.78 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-07-000201 · wil762.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,302.87

Underlying: Common Stock, $0.10 par value · 375.78 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 29, 2007 Filed Jul 3, 2007 20:05 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 407.69 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-07-000165 · wil746.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878.99

Underlying: Common Stock, $0.10 par value · 407.69 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 29, 2007 Filed Jan 29, 2008 22:00 UTC Amendment BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 502.69 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-08-000028 · wil781.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,973.99

Underlying: Common Stock, $0.10 par value · 502.69 shares

Expires not disclosed

F1 · shares: This form is being amended to correct the number of deferred share units accrued as of June 2007.

F2 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F3 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 30, 2007 Filed Apr 3, 2007 19:47 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 427.78 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-07-000102 · wil696.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,428.64

Underlying: Common Stock, $0.10 par value · 427.78 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2007 Filed Feb 5, 2007 21:45 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 3,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-07-000045 · wil652.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000.86

Underlying: Common Stock, $0.10 par value · 3,500 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 29, 2006 Filed Jan 3, 2007 20:19 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 404.45 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-07-000014 · wil640.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496.08

Underlying: Common Stock, $0.10 par value · 404.45 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 29, 2006 Filed Oct 3, 2006 21:06 UTC BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 GrantDeferred Share Units · Derivative 90.6 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000014272-06-000211 · wil619.xml · derivative · entry 1

Williams R Sanders · CIK 0001375347 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90.6

Underlying: Common Stock, $0.10 par value · 90.6 shares

Expires not disclosed

F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.